Skip to main content

Closed

DYN: Dyne Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-58.3%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-52.1×

Current ratio12.02×

Dyne Therapeutics, Inc.

DYNNASDAQ Global Select·USD·Closed

Dyne Therapeutics, Inc.

DYNNASDAQ·USD·Closed

$25.18

−2.14%

$25.18

−$0.55 (2.14%)

52W Range

94thpctl

Volume

0.87×avg

Mkt Cap

4.70BUSD

P/E

-7.6TTM

Div Yield

–ann

52W Range

94thpctl

Volume

0.87×avg

Market Cap

4.70BUSD

P/E Ratio

-7.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings